News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Read more
Show me:
Showing 800 articles
Image
News placeholder image
06.11.2025

Your stories of stigma

We're highlighting stories from people with diabetes to raise awareness of life with diabetes and the imp...
Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk